Enzolytics (Enzolytics) Total Operating Expense : $1.92 Mil (TTM As of Jun. 2011)

View and export this data going back to 2008. Start your Free Trial

What is Enzolytics Total Operating Expense?

Enzolytics's Total Operating Expense for the three months ended in Jun. 2011 was $0.23 Mil. Enzolytics's Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2011 was $1.92 Mil.

Enzolytics Total Operating Expense Historical Data

The historical data trend for Enzolytics's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzolytics Total Operating Expense Chart

Enzolytics Annual Data

Trend

Dec07

Jul08

Dec09

Dec10

Total Operating Expense

0.04

0.06

0.95

2.91

Enzolytics Quarterly Data
	Sep07	Dec07	Apr08	Jul08	Dec08	Mar09	Jun09	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11
Total Operating Expense	Get a 7-Day Free Trial										0.95	0.63	0.81	0.25	0.23

Enzolytics Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.

Total Operating Expense for the trailing twelve months (TTM) ended in Jun. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $1.92 Mil.

Enzolytics Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Enzolytics's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Enzolytics (Enzolytics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Enzolytics Inc (OTCPK:ENZC) » Definitions » Total Operating Expense

Traded in Other Exchanges

N/A

Address

1101 Raintree Circle, Suite 130, Allen, TX, USA, 75013

Website

https://www.enzolytics.com

Enzolytics Inc is a biotechnology company, whose products consist of multiple distinct drug development proprietary technologies: Immunotherapy, immune modulators, fully human monoclonal antibodies, and an artificial intelligence (AI) platform for health care developments. It has clinically tested anti-HIV therapeutics. Additionally, the Company has created a proprietary cell line that produces fully human monoclonal antibodies that target and neutralizes the HIV virus.